---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-105298"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:50:28.252081+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Iradimed reports record Q3 revenue of $21.2M, up 16% YoY; raises FY2025 guidance

## Summary
- GAAP diluted EPS $0.43, non-GAAP diluted EPS $0.47; net income $5.6M (+10% YoY).
- Full-year 2025 guidance raised: revenue $82.5M-$83.5M, GAAP EPS $1.68-$1.72, non-GAAP EPS $1.84-$1.88.
- Declares quarterly dividend of $0.17/share, payable Nov 25, 2025, record date Nov 14, 2025.
- Next-generation 3870 MRI-compatible IV pump on track for limited commercial shipments Dec 2025, full rollout Q1 2026.

## SEC filing metadata
- accession: 0001104659-25-105298
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000110465925105298/0001104659-25-105298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000110465925105298/irmd-20251103x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-105298
- JSON: https://secwatch.observer/filing/0001104659-25-105298.json
- Plain text: https://secwatch.observer/filing/0001104659-25-105298.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.